Qube Research & Technologies (QRT)’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-39,340
Closed -$44.1K 3764
2025
Q2
$44.1K Buy
39,340
+6,519
+20% +$7.96K ﹤0.01% 3172
2025
Q1
$37.7K Buy
+32,821
New +$61K ﹤0.01% 3157
2023
Q4
Sell
-936
Closed -$7.82K 4516
2023
Q3
$7.82K Buy
+936
New +$7.94K ﹤0.01% 3365
2022
Q1
Sell
-32,202
Closed -$944K 2704
2021
Q4
$944K Buy
+32,202
New +$1.6M 0.01% 1225
2020
Q4
Sell
-3,352
Closed -$247K 1987
2020
Q3
$247K Buy
+3,352
New +$198K ﹤0.01% 1320
2020
Q2
Sell
-8,722
Closed -$490K 1843
2020
Q1
$490K Buy
+8,722
New +$382K 0.02% 573

Other funds holding IGMS

Qube Research & Technologies (QRT)'s IGMS Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 39,340 shares — an estimated $44.1K sold.

Qube Research & Technologies (QRT) first reported a position in IGMS in Q1 2020 and held it in 6 quarters. The position peaked at $944K in Q4 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 39,340 IGM Biosciences shares in Q3 2025, an estimated $44.1K.
  • Qube Research & Technologies (QRT) first reported a position in IGM Biosciences in Q1 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s IGM Biosciences position peaked at $944K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.